H. Ralph Snodgrass - 31 Dec 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
PRES./CHIEF SCIENTIFIC OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
31 Dec 2021
Net transactions value
+$6,005
Form type
4
Filing time
03 Jan 2022, 15:19:23 UTC
Previous filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $6,005 +3,623 +5.9% $1.66 64,958 31 Dec 2021 Direct F1
holding VTGN Common Stock 33,901 31 Dec 2021 By H. Ralph Snodgrass Living Trust, dated 10/2/2008
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)